Abstract
Topiramate is one of the currently most promising compounds in the field of addiction medicine. This paper discusses its potential utility related to a phase model of addiction development, focusing on the assumption that addiction is a continuous process involving different neurobiological pathways, depending on the stage of addiction. A specific emphasis will be made on the development of dysfunctional automatic behaviors in the late stage of addiction and the central role of glutamate and AMPA receptors. The aim is to propose that if too broad an effect of anti-addiction medication is expected (such as anti-craving, anti-relapse and preventive effects), the results might be disappointing. The speculative specific efficacy of topiramate in addiction is described.
Keywords: Topiramate, addictions, treatment, drug abuse, dysfunctional, hedonic, ritualized, amphetamines, morphine, naltrexone, mesolimbic, synaptic, neuroanatomical, vaccines, ethanol, sensitization, kainate
Current Pharmaceutical Design
Title: The Potential Interest of Topiramate in Addictions
Volume: 17 Issue: 14
Author(s): Gabriel Thorens, Joel Billieux, Rita Manghi, Riaz Khan, Yasser Khazaal and Daniele Fabio Zullino
Affiliation:
Keywords: Topiramate, addictions, treatment, drug abuse, dysfunctional, hedonic, ritualized, amphetamines, morphine, naltrexone, mesolimbic, synaptic, neuroanatomical, vaccines, ethanol, sensitization, kainate
Abstract: Topiramate is one of the currently most promising compounds in the field of addiction medicine. This paper discusses its potential utility related to a phase model of addiction development, focusing on the assumption that addiction is a continuous process involving different neurobiological pathways, depending on the stage of addiction. A specific emphasis will be made on the development of dysfunctional automatic behaviors in the late stage of addiction and the central role of glutamate and AMPA receptors. The aim is to propose that if too broad an effect of anti-addiction medication is expected (such as anti-craving, anti-relapse and preventive effects), the results might be disappointing. The speculative specific efficacy of topiramate in addiction is described.
Export Options
About this article
Cite this article as:
Thorens Gabriel, Billieux Joel, Manghi Rita, Khan Riaz, Khazaal Yasser and Fabio Zullino Daniele, The Potential Interest of Topiramate in Addictions, Current Pharmaceutical Design 2011; 17 (14) . https://dx.doi.org/10.2174/138161211796150864
DOI https://dx.doi.org/10.2174/138161211796150864 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nitric-Oxide Releasing Molecules : A New Class of Drugs with Several Major Indications
Current Pharmaceutical Design Magnetic Resonance-Based Metabolomics for Understanding Neurological Disorders: Current Status and Statistical Considerations
Current Metabolomics The Host Complement System and Arbovirus Pathogenesis
Current Drug Targets Comorbid Attention Deficit/Hyperactivity Disorder and Substance Use Disorder: Treatment Considerations
Current Drug Abuse Reviews Takotsubo Syndrome: Clinical Manifestations, Etiology and Pathogenesis
Current Cardiology Reviews Epidural Analgesia in the Post-Anaesthesia Care Unit
Current Drug Targets Pramipexole Responsive Neck Numbness: The Therapeutic Role of Dopamine Agonists in the Spinal Cord Indicating to a Common Spinal Pathophysiology with Restless Leg Syndrome (RLS)?
Current Clinical Pharmacology The Neuroprotective Role of PEDF: Implication for the Therapy of Neurological Disorders
Current Molecular Medicine Analysis of Asiaticoside in Beagle Dog Plasma by Liquid Chromatography/ Electrospray Ionization Tandem Mass Spectrometry and its Application to Pharmacokinetic Studies
Current Pharmaceutical Analysis Aptamer-Targeted Oligonucleotide Theranostics: A Smarter Approach for Brain Delivery and the Treatment of Neurological Diseases
Current Topics in Medicinal Chemistry Graphical Abstracts:
Central Nervous System Agents in Medicinal Chemistry Do Rheumatoid Arthritis Patients Rate their Health Status Different than their Caregivers?
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Nesfatin-1; Implication in Stress and Stress-associated Anxiety and Depression
Current Pharmaceutical Design Human Cognitive and Neuro-Psychiatric Bio-Markers in the Cardiac Peri-Operative Patient
Current Molecular Medicine MRI Radiomics Classification and Prediction in Alzheimer’s Disease and Mild Cognitive Impairment: A Review
Current Alzheimer Research Genetic Vulnerability to Psychosis and Cortical Function: Epistatic Effects between DAAO and G72
Current Pharmaceutical Design Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer
Current Medicinal Chemistry Synthesis and Characterization of New Galanthamine Derivatives Comprising Peptide Moiety
Protein & Peptide Letters Chemokine Receptors as Targets for Cancer Therapy
Current Pharmaceutical Design Author Index to Volume 1
Current Neurovascular Research